Nothing Special   »   [go: up one dir, main page]

RU94008616A - 2-THIOSUBLISHED CARBAPENES, INTERMEDIATE CONNECTIONS FOR OBTAINING, METHODS OF OBTAINING, PHARMACEUTICAL COMPOSITION, METHOD OF TREATING BACTERIAL INFECTIONS - Google Patents

2-THIOSUBLISHED CARBAPENES, INTERMEDIATE CONNECTIONS FOR OBTAINING, METHODS OF OBTAINING, PHARMACEUTICAL COMPOSITION, METHOD OF TREATING BACTERIAL INFECTIONS

Info

Publication number
RU94008616A
RU94008616A RU94008616/04A RU94008616A RU94008616A RU 94008616 A RU94008616 A RU 94008616A RU 94008616/04 A RU94008616/04 A RU 94008616/04A RU 94008616 A RU94008616 A RU 94008616A RU 94008616 A RU94008616 A RU 94008616A
Authority
RU
Russia
Prior art keywords
obtaining
bacterial infections
methods
thiosublished
carbapenes
Prior art date
Application number
RU94008616/04A
Other languages
Russian (ru)
Other versions
RU2130457C1 (en
Inventor
Лин Янг-И
Бита Панайота
Сакиа Субас
В.Стромейер Тимоти
Буш Карен
Original Assignee
Американ Цианамид Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Американ Цианамид Компани filed Critical Американ Цианамид Компани
Publication of RU94008616A publication Critical patent/RU94008616A/en
Application granted granted Critical
Publication of RU2130457C1 publication Critical patent/RU2130457C1/en

Links

Claims (1)

Настоящее изобретение относится к новым антибиотикам группы карбапенемов и их нетоксичным фармацевтически приемлемым солям, обладающим антимикробной активностью, которые могут быть использованы как отдельно, так и в сочетании с другими антибиотиками для лечения бактериальных инфекций у человека и животных. Настоящее изобретение также относится к способу получения антибиотиков группы карбапенемов и некоторых новых промежуточных соединений. Представлены способы лечения инфекционных заболеваний человека и животных, предусматривающие введение указанных выше новых соединений человеку или животным, а также фармацевтические препараты, содержащие эти соединения.The present invention relates to carbapenem antibiotics and their non-toxic pharmaceutically acceptable salts with antimicrobial activity, which can be used both alone and in combination with other antibiotics to treat bacterial infections in humans and animals. The present invention also relates to a method for producing antibiotics of the carbapenem group and some novel intermediates. Presents methods for the treatment of infectious diseases in humans and animals, involving the introduction of the above new compounds to humans or animals, as well as pharmaceutical preparations containing these compounds.
RU94008616/04A 1993-03-16 1994-03-15 2-thiosubstituted carbapenems, intermediate compounds for synthesis, methods of synthesis (variants), pharmaceutical composition RU2130457C1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3368493A 1993-03-16 1993-03-16
US08/033684 1993-03-16
US08/033.684 1993-03-16

Publications (2)

Publication Number Publication Date
RU94008616A true RU94008616A (en) 1995-11-10
RU2130457C1 RU2130457C1 (en) 1999-05-20

Family

ID=21871845

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94008616/04A RU2130457C1 (en) 1993-03-16 1994-03-15 2-thiosubstituted carbapenems, intermediate compounds for synthesis, methods of synthesis (variants), pharmaceutical composition

Country Status (19)

Country Link
US (4) US5602118A (en)
EP (1) EP0617036A3 (en)
JP (1) JPH06321948A (en)
KR (1) KR100353751B1 (en)
CN (3) CN1482122A (en)
AU (1) AU676877B2 (en)
CA (1) CA2118961A1 (en)
CZ (1) CZ290494B6 (en)
FI (1) FI106718B (en)
HU (2) HUT67741A (en)
IL (1) IL108939A0 (en)
NO (1) NO311939B1 (en)
NZ (1) NZ260102A (en)
PL (1) PL179558B1 (en)
RU (1) RU2130457C1 (en)
SG (2) SG91908A1 (en)
SK (1) SK31694A3 (en)
TW (1) TW474937B (en)
ZA (1) ZA941828B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69942571D1 (en) * 1998-04-23 2010-08-26 Dentsply Detrey Gmbh Storage-resistant polymerizable composition
CA2339147C (en) * 1998-08-04 2009-04-21 Fujisawa Pharmaceutical Co., Ltd. Stabilized preparations of .beta.-lactam antibiotic
US6162924A (en) * 1999-04-09 2000-12-19 Eastman Chemical Company Process for halohydrin preparation
EP1282445A2 (en) * 2000-03-21 2003-02-12 Atherogenics, Inc. N-substituted dithiocarbamates for the treatment of biological disorders
US6649756B2 (en) * 2000-07-13 2003-11-18 Wyeth, Five Giralda Farms Process improvement in the preparation of (4r, 5s, 6s)-3-[[(2r,3r)-2-[[[(s)-2-amino-3-methyl-1-oxobutyl]amino]methyl]tetrahydro-3-furanyl]thio]-6-[(r)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
US20020049315A1 (en) * 2000-09-06 2002-04-25 Williams John M. Crystalline forms of carbapenem intermediates
US6818787B2 (en) * 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) * 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) * 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US20050152887A1 (en) * 2004-01-14 2005-07-14 Doctor's Signature Sales And Marketing International Corp. [Dba Life Force International Protonic formulation
KR100621782B1 (en) * 2004-06-14 2006-09-19 한국과학기술연구원 1?-methylcarbapenem derivative and process for the preparation thereof
CN102964239B (en) * 2005-09-22 2016-01-20 明治制果药业株式会社 metal-beta-lactamase inhibitor
US8119667B2 (en) * 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
US8093378B2 (en) * 2006-04-28 2012-01-10 Kaneka Corporation Crystallization method for intermediates of carbapenem antibiotics
EP2066649A1 (en) * 2006-07-28 2009-06-10 KRKA, tovarna zdravil, d.d., Novo mesto Process for the preparation of amorphous and crystalline forms of candesartan cilexetil using column chromatography
WO2009114921A1 (en) * 2008-03-17 2009-09-24 Dmitrienko Gary I INHIBITORS OF CLASS B AND CLASS D β-LACTAMASES
US20110118462A1 (en) * 2009-11-18 2011-05-19 Guangzhou Baiyunshan Pharmaceutical Co., Ltd. Guangzhou Baiyunshan Pharmaceutical Factory N-heterocyclic substituent-containing antibiotic, preparation and use thereof
US10093660B2 (en) 2013-12-04 2018-10-09 Evotec Internatonal Gmbh Sulfoximine substituted quinazolines for pharmaceutical compositions
US11180504B2 (en) 2016-03-16 2021-11-23 Orchid Pharma Ltd. Substituted carbapenems for the treatment of bacterial infections

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2656362A (en) * 1951-07-05 1953-10-20 Allied Lab Inc Preparation of 2-halogenated tetrahydrothiophene 1, 1-dioxides
GB1441177A (en) * 1973-12-13 1976-06-30 Beheer Bv Pfw Sulphur-containing flavouring agents
CS176325B1 (en) * 1975-01-31 1977-06-30
US4347368A (en) * 1977-10-19 1982-08-31 Merck & Co., Inc. 3-Substituted-6-substituted-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
US4260627A (en) * 1978-10-24 1981-04-07 Merck & Co., Inc. 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids
DK446179A (en) * 1978-10-24 1980-05-29 Merck & Co Inc PROCEDURE FOR PREPARING SUBSTITUTED 1-CARBADETHYAPE-2-EM-3-CARBOXYL ACIDS
US4232036A (en) * 1978-10-24 1980-11-04 Merck & Co., Inc. 6-, 1- and 2-Substituted-1-carbadethiapen-2-em-3-carboxylic acids
US4341706A (en) * 1980-10-10 1982-07-27 Merck & Co., Inc. Process for the preparation of carbapenem antibiotics
US4745188A (en) * 1980-11-21 1988-05-17 Merck & Co., Inc. Process for preparing 3-substituted-6-substituted-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
EP0060612A1 (en) * 1981-02-04 1982-09-22 Beecham Group Plc Process for the preparation of azabicyclo(3.2.0)-hept-2-ene derivatives
NZ201471A (en) * 1981-08-10 1985-09-13 Merck & Co Inc Antibacterial compositions containing penems and dipeptidase inhibitors
US4552873A (en) * 1981-08-19 1985-11-12 Sankyo Company Limited Carbapenem compounds, and compositions containing them
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS60202886A (en) * 1984-03-27 1985-10-14 Sankyo Co Ltd 1-substituted carbapenem-3-carboxylic acid derivative and its preparation
US4696923A (en) * 1984-04-23 1987-09-29 Merck & Co., Inc. 6-[1-hydroxyethyl]-2-SR8 -1-methyl-1-carbadethiapen-2-em-3-carboxylic acids
US4820817A (en) * 1984-09-10 1989-04-11 Merck & Co., Inc. Process for preparing 3-substituted-6-substituted-7-oxo-1-azabicycl(3.2.0)-hept-2-ene-2-carboxylic acid
DE3579888D1 (en) * 1984-11-08 1990-10-31 Sumitomo Pharma CARBAPENE COMPOUNDS AND THEIR PRODUCTION.
JPH075463B2 (en) * 1985-03-09 1995-01-25 サントリー株式会社 Antibacterial agent
US4665169A (en) * 1985-09-11 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
ES2059679T3 (en) * 1988-11-08 1994-11-16 Daiichi Seiyaku Co DERIVATIVES OF CARBAPENEM.
US5321020A (en) * 1989-03-28 1994-06-14 Pfizer Inc. Antibacterial 2-carbapenem derivatives
WO1990011284A1 (en) * 1989-03-28 1990-10-04 Pfizer Inc. Antibacterial 2-carbapenem derivatives
CA2022382A1 (en) * 1989-08-02 1991-02-03 Susumu Nakagawa Piperidylthiocarbapenem derivatives
EP0942000B1 (en) * 1989-10-24 2004-06-23 Isis Pharmaceuticals, Inc. 2'-Modified oligonucleotides
WO1991009860A1 (en) * 1989-12-28 1991-07-11 Banyu Pharmaceutical Co., Ltd. New carbapenem derivative
CA2037767A1 (en) * 1990-03-23 1991-09-24 Mark D. Wittman Conversion of amines to hydroxylamines
US5116833A (en) * 1990-10-19 1992-05-26 Bristol-Myers Squibb Company Antibiotic c-3 dithioacetal-substituted carbapenem compounds, compositions, and methods of use thereof
JPH04368386A (en) * 1991-06-18 1992-12-21 Sankyo Co Ltd Production of 1-methylcarbapenem-3-carboxylic acid
GB9202298D0 (en) * 1992-02-04 1992-03-18 Ici Plc Antibiotic compounds

Similar Documents

Publication Publication Date Title
RU94008616A (en) 2-THIOSUBLISHED CARBAPENES, INTERMEDIATE CONNECTIONS FOR OBTAINING, METHODS OF OBTAINING, PHARMACEUTICAL COMPOSITION, METHOD OF TREATING BACTERIAL INFECTIONS
EA199901015A1 (en) 4 "-SUBSTITUTED DERIVATIVES 9-DEOXO-9A-A3A-9A-HOMOERITROMYCIN A
NO942468D0 (en) Process for the preparation of 2-alkyl-3,4,6-trifluorobenzoic acid
EG20001A (en) Process for preparing of novel hydrox-amic acid and N-hydroxyurea derivatives and their use
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
DE3462255D1 (en) Quinolone carboxylic acids, process for their preparation and antibacterial compositions containing them
PT806941E (en) LIPOSOMIC ANTI-BACTERIAL COMPOSITIONS OF LOW RIGIDITY
RU93004457A (en) 1-CARBES- (1-DETIA) -CEFITS AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION
CA2351429A1 (en) 13-membered azalides and their use as antibiotic agents
RU94020410A (en) Method of vomiting treatment or prophylaxis in mammalian and human using the certain quinuclidine, piperidine, azanorbornane, ethylenediamine derivatives and related compounds
DE69932939D1 (en) FULVIC ACID AND ITS USE FOR THE TREATMENT OF VARIOUS DISEASE STATES
RU99107569A (en) PHARMACEUTICAL COMPOSITIONS Possessing Antimicrobial Activity
ATE202709T1 (en) COMPOSITIONS THAT CONTAIN G-CSF AND A TNF BINDING PROTEIN
ATE246192T1 (en) ETHYLIDE DERIVATIVES TRICYCLYCLYC CARBAPENEMS
WO1998006265A3 (en) Treatment of fungal infections using a combination of an anti-fungal compound and an n-alkyl-heterocyclic compound, especially n-dodecyl-morpholine
CA2037779A1 (en) Antibiotic ge 2270 factors b1, b2, c1, c2, d1, d2, e and t
EA200001029A1 (en) HYGROMYCIN DERIVATIVES
CA2077102A1 (en) Antibiotic ge 2270 factor c2a
DE69109314D1 (en) Human monoclonal antibody and pharmaceutical composition containing it for the treatment of Pseudomonas infections.
DE69317058D1 (en) THE ANTIBIOTICS GE 37468 A, B AND C
DK15088A (en) ANTIBACTERIAL LYOPHILIZED PREPARATION
IE36346B1 (en) Antibacterial agents and a process for the preparation thereof
RU1524224C (en) Preparation for treatment of lambs with necrobacteriosis and ecthyma
ATE210445T1 (en) USE OF 2-AMINOPURINE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HUMAN HERPES VIRUS 7 INFECTIONS
SU1629062A1 (en) Method for treatment of calves with colibacillosis